Vascular Stent Market highly efficient technology developed by growth drivers 2025

Global Vascular Stent Market: Overview

As the incidence of peripheral artery disease grows, the global demand for vascular stents is expected to swell as well. Vascular stents are medical devices that are usually placed as part of peripheral artery angioplasty. In simple terms, a stent is a plastic or metal tube that is inserted into an anatomic vessel so as to keep the passageway from closing. Iliac, carotid, and femoral arteries are some common sites which are treated with vascular stents.

Global Vascular Stent Market: Key Trends

The growing prevalence of peripheral vascular disease (PVD), which is alternatively known as peripheral artery disease (PAD), is one of the primary growth drivers of the global vascular stents market. According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 8 million in the U.S. alone suffer from peripheral artery disease. Of these, 12 to 20% of the patients are above the age of 60, finds the study. Thus, it has been understood that the geriatric population is at a higher risk of suffering from peripheral artery disease. Since the aging population has been escalating at a rapid pace, the global vascular stent market will witness greater growth.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2618

On the downside, the exorbitant costs of these devices might hinder the growth of the global vascular stent market. However, as a number of market vendors have been developing highly efficient and accurate imaging techniques, the market for vascular stents is likely to receive a boost.

Global Vascular Stent Market: Market Potential

A number of market players are concentrating on the introduction of innovative products, enhancing the ease of use for healthcare providers as well as patients. The researchers at the Technische Universiteit, Eindhoven (Eindhoven University of Technology) have acknowledged the special challenge presented by pediatric patients. The creation of customized stents is not a novel phenomenon. The researchers have produced a relatively better vascular stent, according to an announcement made in May 2017.

The new stent can expand as the child grows, biodegrading with time, as against conventional stents that children outgrow. The traditionally used metal stents can also lead to complications including hyperplasia. In order to design this 3D printable, self-expanding stent, a computational model of a nickel titanium stent was built by the researchers.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=2618

Several other products are receiving regulatory approvals. For instance, in the same month, Alucent Medical, Inc. announced that it received the approval of the U.S. Food and Drug Administration (FDA) to commence Phase I human clinical studies of its new drug/device combination therapy for treating peripheral vascular disease.

Global Vascular Stent Market: Regional Outlook

The global vascular stent market can be segmented into Europe, Latin America, North America, the Middle East and Africa, and Asia Pacific. North America has currently been leading the global vascular stent market, with the U.S. as the chief contributor. The growing patient base and rising concentration of geriatric populace have been driving the growth of this region.

Asia Pacific, driven by augmenting acceptance of cutting-edge technologies, is slated to display fastest rate of growth over the forthcoming period. The low costs of manufacturing, presence of a large number of market participants, and growing incidence of cardiovascular diseases have been assisting the growth of the global vascular stent market.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/vascular-stent-market

Global Vascular Stent Market: Competitive Analysis

MicroPort Scientific Corporation, Vascular Concepts, Medtronic, plc, B. Braun Melsungen AG, STENTYS SA, Lombard Medical Technologies, Abbott Laboratories, BIOTRONIK SE & Co. KG, Meril Life Sciences Pvt. Ltd., W. L. Gore and Associates, Boston Scientific Corporation, and Endologix, Inc. are some key vendors operating in the global vascular stent market.

Product Innovation Promotes Vascular Stents Market

San Francisco, California, March 12, 2018: A recent market study by TMR Research, titled, “Vascular Stent Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017–2025,” finds that savvy players in the market are focusing hard on product development to improve sales and revenues. This is has resulted in many new innovative products being launched at regular intervals. The global market for vascular stent is receiving a major boost on account of it, along with the rising occurrence of peripheral vascular disease (PVD), also known as peripheral artery disease (PAD). The latter driver for the market is mainly owing to the burgeoning geriatric population worldwide.

Get Sample Copy of this Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2618

Providing headwinds to the otherwise promising market growth, on the other hand, is the steep cost of vascular stents. However, with thrust on customized stents has opened up new avenues for growth in the market. Apart from that, effective and accurate imaging techniques is also acting as a catalyst for the market.

From a geographical standpoint, the global market for vascular stents at present is led by North America. The growth in the region is mainly powered by the U.S. which has a large patient pool due to a massive elderly population. Asia Pacific is another key region, which is being driven by the rapid uptake of cutting edge technologies for healthcare in the region. Besides, low manufacturing costs and rising instances of cardiovascular diseases in the region, coupled with numerous manufacturers of vascular stents being domiciled there is also augmenting growth in the market.

Some of the prominent participants in the global market for vascular stents are Vascular Concepts, MicroPort Scientific Corporation, B. Braun Melsungen AG, Medtronic, plc, Lombard Medical Technologies, Meril Life Sciences Pvt. Ltd., Abbott Laboratories, and Associates, and Boston Scientific Corporation.